Selection and characterization of β-lactam-β-lactamase inactivator- resistant mutants following PCR mutagenesis of the TEM-1 β-lactamase gene

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1542-1548

  Vakulenko, Sergei B ^a   Geryk, Bruce ^a   Kotra, Lakshmi P ^b   Mobashery, Shahriar ^b   Lerner, Stephen A ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE TEM 1; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; KANAMYCIN; SULBACTAM; TAZOBACTAM; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; ENZYME INACTIVATION; ENZYME INHIBITION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0031834415     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1542     Document Type: Article

References (31)

1. Ambler, R. P., A. F. W. Coulson, J. M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tyraby, and S. G. Waley. 1991. A standard numbering scheme for class A β-lactamases. Biochem J. 276:269-272.
2. Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequence of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
3. Blasquez, J., M.-R. Baquero, R. Canton, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
4. Bonomo, R. A., C. G. Dawes, J. R. Knox, and D. M. Shlaes. 1995. Complementary roles of mutations at positions 69 and 242 in a class A β-lactamase. Biochim. Biophys. Acta 1247:113-120.
5. Bret, L., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1996. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. J. Antimicrob. Chemother. 38:183-191.
6. Brown, R. P., R. T. Aplin, and C. J. Schofield. 1996. Inhibition of TEM-2 β-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry. Biochemistry 35:12421-12432.
7. Brun, T., J. Peduzzi, M. M. Canica, G. Paul, P. Nevot, M. Barthelemy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microbiol. Lett. 120:111-118.
8. Bulychev, A., M. E. O'Brien, I. Massova, M. Teng, T. A. Gibson, M. J. Miller, and S. Mobashery. 1995. Potent mechanism-based inhibition of the TEM-1 β-lactamase by novel N-sulfonyloxy β-lactams. J. Am. Chem. Soc. 117:5938-5943.
9. Bush, K., C. Macalintal, B. A. Rasmussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother. 37:851-858.
10. Henquell, C., D. Sirot, C. Chanal, C. De Champs, P. Charton, B. Lafeuille, P. Texier, J. Sirot, and R. Cluzel. 1994. Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France. J. Antimicrob. Chemother. 34:707-714.
11. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
12. Imtiaz, U., E. M. Billings, J. R. Knox, and S. Mobashery. 1994. A structurebased analysis of the inhibition of class A β-lactamases by sulbactam. Biochemistry 33:5728-5738.
13. Imtiaz, U., E. M. Billings, J. R. Knox, E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1993. Inactivation of class A β-lactamases by clavulanic acid: the role of arginine-244 in a non-concerted sequence of events. J. Am. Chem. Soc. 115:4435-4442.
14. Jacob, F., B. Joris, S. Lepage, J. Dusart, and J.-M. Frère. 1990. Role of the conserved amino acids of the SDN loop (Ser-130, Asp-131, and Asn-132) in a class A β-lactamase studied by site-directed mutagenesis. Biochem. J. 271:399-406.
15. Jelsch, C., L. Mourey, J. M. Mason, and J.-P. Samama. 1993. Crystal structure of Escherichia coli TEM1 β-lactamase at 1.8 Å resolution. Proteins 16: 364-383.
16. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
17. Kraulis, P. J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-950.
18. Lamotte-Brasseur, J., F. Jacob-Dubuisson, G. Dive, J.-M. Frère, and J.-M. Ghuysen. 1992. Streptomyces albus G serine β-lactamase. Probing of the catalytic mechanism via molecular modeling of mutant enzymes. Biochem. J. 282:189-195.
19. Lemozy, J., D. Sirot, C. Chanal, C. Hue, R. Labia, H. Dabernat, and J. Sirot. 1995. First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 33:2580-2582.
20. Martinez, J. L., M. F. Vicente, A. Delgado-Iribarren, J. C. Perez-Diaz, and F. Baquero. 1989. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother. 33:595.
21. Matagne, A., and J.-M. Frère. 1995. Contribution of mutant analysis to the understanding of enzyme catalysis: the case of class A β-lactamases. Biochim. Biophys. Acta 1246:109-126.
22. Oliphant, A. R., and K. Struhl. 1989. An efficient method for generating proteins with altered enzymatic properties: application to β-lactamase. Proc. Natl. Acad. Sci. USA 86:9094-9098.
23. Prinarakis, E. E., V. Miriagou, E. Tzelepi, M. Gazouli, and L. S. Tzouvelekis. 1997. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob. Agents Chemother. 41:838-840.
24. Reguera, J. A., F. Baquero, J. C. Penez-Diaz, and J. L. Martinez. 1991. Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli. J. Antimicrob. Chemother. 27:569-575.
25. Sanders, C. C., J. P. Iaconis, G. P. Bodey, and G. Samonis. 1988. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob. Agents Chemother. 32:1365-1369.
26. Saves, I., O. Burlet-Schiltz, P. Swaren, F. Lefevre, J.-M. Masson, J.-C. Prome, and J.-P. Samama. 1995. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the β-lactamase resistance to clavulanic acid. J. Biol. Chem. 270:18240-18245.
27. Stapleton, P., P.-J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
28. Thomson, C. J., and S. G. B. Amyes. 1993. Selection of variants of the TEM-1 β-lactamase, encoded by a plasmid of clinical origin, with increased resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 31:655-664.
29. Vedel, G., A. Belaaouaj, L. Gilly, A. Philippon, P. Nevot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
30. Zafaralla, G., E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1992. Elucidation of the role of arginine-244 in the turnover process of class A β-lactamases. Biochemistry 31:3847-3852.
31. Zhou, X. Y., F. Bordon, D. Sirot, M.-D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.